We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Latest Products in Molecular Diagnostics, Biochemistry, Immunology and POC Testing

By LabMedica International staff writers
Posted on 31 Jul 2024
Print article
Image: The Panall 8000 All-in-one Molecular Diagnosis system is being showcased at ADLM 2024 (Photo courtesy of Tianlong)
Image: The Panall 8000 All-in-one Molecular Diagnosis system is being showcased at ADLM 2024 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) is showcasing its latest instruments, covering a wide range of products and solutions in molecular diagnostics, biochemistry, immunology, POCT, and more at ADLM 2024.

Visitors at Tianlong’s booth at the show can engage in interactive exchanges, explore the latest industry trends and technological innovations, and learn about the unique features and technical advantages of the company’s products while engaging in meaningful discussions with its expert team. At ADLM 2024, Tianlong is featuring the Gentier X3 Series Real-Time PCR System which has a high throughput of up to 96 tests per hour and provides the excellent function of running a maximum of 3×32-well samples in three different protocols on three independent thermal blocks simultaneously.

Tianlong is also demonstrating the Biolum Portable ATP Hygiene Monitoring System Pro which generates results in just 10 seconds, with a sensitivity of up to 10-16 mol of ATP. The intuitive smartphone design with a 5-inch touch shatter-proof screen ensures user-friendly operation. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities. Additionally, Tianlong is offering demonstrations of the Panall 8000 an all-in-one molecular diagnosis system that integrates the features of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis, achieving a true sample-in-result-out detection process. Tianlong’s Panall 8000 is now OPEN to be compatible with PCR reagents from different manufacturers.

Related Links:
Tianlong Science and Technology

New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
RFID Tag
AD-302 M730
New
Dehydroepiandrosterone Assay
DHEA ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Low levels of a protein that signals placental development could alert physicians to the need for enhanced monitoring (Photo courtesy of Shutterstock)

Blood Test Could Identify Expectant Mothers at Risk of Preterm Delivery

Early preterm birth, defined as delivery before 34 weeks of gestation, carries significant risks for adverse health outcomes. However, there is no universal screening strategy available, which limits the... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.